期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 156, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113871
关键词
Cancer pain; Pharmacology; Opioids; Sarcoma; NSAID; Acetaminophen; Antidepressant
资金
- National Heart, Lung, and Blood Institute (NHBLI) [5K01HL144882-3]
- Center for Redox Biology and Cardiovascular Disease Grant [3P20GM121307-03S1]
Patients diagnosed with cancer often experience pain during treatment, and concerns about adverse effects and addiction may result in under-dosing of opioids. Therefore, there is a need for novel non-opioid pain treatments for cancer patients.
Patients diagnosed with cancer often experience pain during their treatment course, making it difficult to care for themselves and continue with their activities of daily living. When cancer is found at later stages, the pain can become severe and constant; reducing their quality of life and significantly affecting mental and physical well-being. Despite opioids being known to provide adequate analgesia for higher pain levels, they are often the reason for under-dosing because of their adverse effects and concern for addiction. There are also patients who do not respond well to opioids because of genetic anomalies or personal preference. Therefore, there is a need for novel non-opioid cancer pain treatments. There are many new cancer pain treatments that are emerging. This manuscript discusses cancer pain, risk factors, epidemiology, guidelines for the treatment of cancer pain, personalization of cancer pain therapy, breakthrough pain, cancer-induced peripheral neuropathy, established cancer pain treatment options, and novel emerging cancer pain treatment options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据